Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Marina Konopleva
MDS/AML metabolism
Jenny Wang
AML
Megan McNerney
AML/MDS
Justine Kahn
pediatric leukemia and lymphoma
Adam de Smith
pediatric ALL and Down Syndrome
Jonathan Licht
DNA biology, myeloma
Eric Pietras
AML
John DiPersio
trispecific antibody for AML and MDS
Taishi Yonezawa
AML
Nirav Shah
CAR-T for lymphoma
Nitin Jain
CLL
Christopher Booth
BPDCN
Stephen Oh
myeloproliferative neoplasms
Jalpa Doshi
Equity in Access
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Dane Vassiliadis
blood cancer biology
Neha Mehta-Shah
T-cell lymphoma
Wendy Stock
T-cell ALL
Ruben Carrasco
Myeloma
Jeffrey Magee
pediatric AML
Wendy Béguelin
follicular lymphoma
Caner Saygin
T-ALL
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Kimberly Stegmaier
childhood blood cancers
Adam Olszewski
Follicular and marginal zone lymphoma
Catherine Bollard
pediatric blood cancers and immunotherapy
Michael Keller
COVID-19, immunotherapy
Matteo Bellone
Smoldering multiple myeloma
Teresa Palomero
Peripheral T-cell Lymphoma
Anthony Letai
improving CAR-T
Yiman Liu
Epigenetics and leukemia
Sam Butterworth
CMML
John Leonard
lymphoma research
Reina Takeda
AML
Ryan Wilcox
T-cell lymphoma
Coleman Lindsley
AML/MDS
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Siddhartha Jaiswal
preleukemia
Dimericon Therapeutics
dimericons, blood cancer
Christopher Flowers
clinical trial access
Srividya Swaminathan
pediatric, immunotherapy
Piers Patten
COVID-19
Armin Rashidi
gut bacteria and transplant success
Oreofe Odejide
Equity in Access
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Takeshi Sugio
T-cell lymphoma
Tak Mak
Immunotherapy
Shannon Maude
Immunotherapy for ALL
Enterome
vaccine, FL, MZL
Adi Nagler
Bronchiolitis obliterans after transplant
Timothy Graubert
AML and MDS biology
Roland Walter
Antibody-based AML therapies
Philippe Armand
follicular lymphoma
Daniel Pollyea
AML
Thomas LeBlanc
palliative care
Sriram Sundaravel
AML stem cells
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Peter Croucher
Multiple Myeloma
Daniel Thomas
Myelofibrosis
Jake Shortt
precision therapy for aggressive lymphomas
Bingyi Chen
AML immunotherapy
Courtney Jones
AML metabolism
Meng Li
Equity in Access
Kerry Rogers
CLL
Richard Lock
T-ALL
Alexey Danilov
lymphoma
Steven Treon
Lymphomas and Waldenstrom's
Helen Parsons
Equity in Access
Huda Salman
CMML
Michael Savona
MDS and leukemia
Carl June
CAR T immunotherapy
Yibin Yang
Lymphoma
Liran Shlush
pre-leukemia
Sigurður Kristinsson
Smoldering myeloma
Martin Dreyling
Mantle Cell Lymphoma
Jeremy Baeten
AML
Siegfried Janz
Myeloma immunotherapy
George Daley
"off-the-shelf" CAR-T and CAR-NK
Carma Bylund
Equity in Access
Stacie Dusetzina
Equity in Access
Venkata Lokesh Battula
immunotherapy and AML
Christopher Porter
Leukemia, lymphoma
Cailin Collins
Leukemia and pre-leukemia
Daniel Lucas
bone marrow and leukemia biology
Christian Steidl
B-cell lymphomas
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Tycel Phillips
Mantle Cell Lymphoma
Steven Park
follicular lymphoma
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Elliot Stieglitz
CMML
Stephen Gottschalk
pediatric leukemia and CAR-T
Christine Zhang
AML
Roberta Zappasodi
lymphoma, immunotherapy
Gaurav Goyal
Erdheim-Chester Disease
Simona Colla
Myeloma biology
Amin Sobh
Myeloma biology
Maximilian Stahl
AML immunotherapy
Eirini Papapetrou
blood cancer stem cells
Julia Paczkowska
immunobiology of Hodgkin's disease
BioInvent International
immunotherapy, indolent NHL, CTCL
Julia Maxson
AML
Inhye Ahn
CLL
Paolo Caimi
CAR-T clinical trial for CLL
Marc Seifert
Hairy cell leukemia
H. Irene Su
Equity in Access
Ricky Johnstone
lymphoma and myeloma
Kasey Leger
pediatric blood cancers
Jolanta Grembecka
leukemia therapeutics
Raymond Mailhot
Equity in Access
Ari Melnick
epigenetics and lymphoma
Mala Shanmugam
myeloma
Bing Carter
p53 mutant AML
Areej El-Jawahri
transplant survivorship
Madhav Dhodapkar
multiple myeloma immunotherapy
Jennifer Lewis
URM Student
Tomasz Skorski
myeloproliferative neoplasms, AML
Alec Zhang
myeloma, immunotherapy
Jianguo Tao
Mantle Cell Lymphoma
Craig Jordan
AML
Frederike Kramer
MPNs
Yoke Seng Lee
AML
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Jonas Jutzi
myeloproliferative neoplasms
Fahmin Basher
transplant and GvHD
Saar Gill
AML immunotherapy
Caron Jacobson
lymphoma and immunotherapy
Affimed
immunotherapy, HL, PTCL
Eugenio Morelli
Myeloma
Gianpietro Dotti
CAR T and AML
Steven Horwitz
T-cell lymphomas
Anushree Vichare
Equity in Access
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Soheil Meshinchi
pediatric AML
Michael Kharas
leukemia
Alfred Garfall
myeloma immunotherapy
Omar Abdel-Wahab
Hairy cell leukemia
Mark Dawson
B-ALL and CAR-T resistance
Alieen Rowan
Adult T cell leukemia/lymphoma
Yubin Zhou
peripheral T cell lymphoma
Marco Ruella
Immunotherapy for T-cell lymphoma
Suzanne Lentzsch
Myeloma
Pooja Khandelwal
bone marrow transplantation
Ronald Levy
immunotherapies, COVID-19
Grant Challen
preleukemia, leukemia
Jayna Mistry
aging and leukemias
Rajni Kumari
AML
Caroline Arber
myeloma CAR-T
Catriona Jamieson
cancer stem cell biology
Mark Hamilton
DLBCL and CAR-T
Grzegorz Nowakowski
Clinical trial access
Enrico Tiacci
Hairy cell leukemia
Keisuke Ito
blood cancer stem cells and MDS metabolism
James Rubenstein
Lymphoma of the Central Nervous System
Arash Alizadeh
blood cancer biology and diagnosis
Hao Jiang
DNA biology and leukemia
Rgenta Therapeutics
RNA-targeting, blood cancer
Michael Wang
Mantle Cell Lymphoma
Mendel Goldfinger
MDS/AML trials for the elderly
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Noemí Puig Morón
Myeloma
Matthew Frank
Lymphoma CART therapy
Sahand Hormoz
MPN
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Suman Paul
T cell cancers and immunotherapy
Joachim Yahalom
Lymphoma
Alex Kentsis
pediatric leukemias
Jean Koff
Disparities in DLBCL
Lori Muffly
Equity in Access
Xu Ji
Equity in Access
Rizwan Romee
Immunotherapy
Ravindra Majeti
preleukemia, AML
Jing Yang
Myeloma
Pietro Genovese
transplant and AML
Thomas Koehnke
leukemia
Sarah Tasian
pediatric leukemias
Paul Beavis
immunotherapy in myeloma
Nataly Cruz-Rodriguez
T-ALL and metabolism
Eric Padron
CMML
Jianhua Yu
myeloma immunotherapy
Constellation Pharmaceuticals
myeloproliferative neoplasms
Randall Davis
CLL
Sisi Chen
leukemia
Susan Schwab
cancer immunology
John Crispino
MPNs, myelofibrosis
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Stephen Nimer
myeloid cancer biology
Nicola Vannini
Aging and CAR-T success
Ann-Kathrin Eisfeld
Racial diversity in AML
Lindsey Montefiori
pediatric leukemia
Ana Vujovic
AML
Solu Therapeutics
immunotherapy, CMML
Andrew Lane
BPDCN
Jennifer Woyach
CLL trials
Shazia Nakhoda
Equity in Access
Carl Allen
pediatric blood cancers
Ravi Bhatia
transplantation
Jeetayu Biswas
splicing in myeloid diseases
Michael Green
lymphoma biology
Jonathon Cohen
lymphoma clinical trial access in Georgia
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Leandro Cerchietti
DLBCL
Jennifer Trowbridge
aging and leukemia
Logan Spector
childhood leukemia epidimiology
Manyi Wei
acute megakaryoblastic leukemia
Lucy Godley
preleukemia
Markus Muschen
leukemia and lymphoma biology
Frederick Locke
lymphoma and immunotherapy
Sergei Doulatov
Leukemias
Lawrence Boise
CART and myeloma
Fenghuang Zhan
Myeloma and bone disease
ImCheck Therapeutics
immunotherapy, AML
Anouchka Laurent
T-cell lymphoma
Jaroslaw Maciejewski
bone marrow failure
Daisuke Nakada
preleukemia, leukemia
Britta Will
Leukemia and pre-leukemia
Lakshmi Nayak
brain tumors in lymphoma
Jun Qi
Myeloma
George Vassiliou
Leukemia Prevention
Yan Liu
MDS
Kathleen Sakamoto
pediatric AML
Bruno Paiva
smoldering myeloma
Catherine Smith
leukemia
Tyler Parsons
MPN and AML
Paolo Strati
Non-Hodgkin Lymphoma
Kura Oncology
MLL leukemia, AML
Nizar Bahlis
Myeloma immunotherapy
Nicoletta Cieri
AML and transplantation
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Luca Busino
DLBCL
Robert Orlowski
(Smoldering) Multiple Myeloma
Rong Lu
preleukemia, leukemia
Amit Verma
AML/MDS
Sheng Li
Aging and AML
Daniel Herranz
T-ALL
Bailee Kain
AML and African ancestry
Kymera Therapeutics
protein degraders, TCL, LGLL, AML
Sham Mailankody
Myeloma immunotherapy clinical trials
Hong Wen
AML
Thomas Kipps
Hairy Cell Leukemia
Jaehyuk Choi
T-cell lymphoma
Michaela Reagan
Multiple Myeloma
Dan Landau
cancer evolution biology
Koichi Takahashi
AML/MDS
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
F. Lennie Wong
Equity in Access
Qing Yi
Novel CAR-T
Courtney DiNardo
clinical trials, AML
Peter Klein
MDS
Brian Walker
smoldering myeloma, MGUS
Lev Kats
myeloma and epigenetics
Margaret Shipp
lymphoma biology
Mark Murakami
follicular lymphoma
Gareth Morgan
smoldering myeloma, MGUS
Nicolas Nassar
pediatric leukemia
Alison Moskowitz
lymphoma therapeutics
Jing Fu
myeloma
Kirk Schultz
pediatric transplantation
Faron Pharmaceuticals
immunotherapy, MDS
Tanya Siddiqi
clinical trial access
Jessica Stewart
Epstein-barr virus and lymphomas
Liling Wan
AML
Robert Soiffer
transplantation
Christian Marinaccio
MLL leukemias
Brian Dalton
DNA mutations and myeloid cancers
William Matsui
Myeloma
Daniel Starczynowski
MDS and AML
Qingyu Luo
BPDCN
Riccardo Dalla-Favera
lymphoma (DLBCL)
Catherine Diefenbach
DLBCL immunology
Trent Hall
MDS
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL